Skip to content

A Phase 1 Study of TORL-1-23 in Advanced Cancer

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517189-40-00
Enrollment
12
Registered
2026-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Interventions

None listed

Sponsors

Torl Biotherapeutics LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 7, 2026